GHK-CU – Research Peptide
US$ 23.70
cjc1295/ipamorelin blend orlando CJC-1295 + Ipamorelin CJC-1295 & Ipamorelin Blend (10mg)
Description
Despite promising preclinical data, clinical trials in humans are extremely limited, and the compound remains largely experimental, with ongoing research required to fully characterize pharmacokinetics, optimal dosing, long-term safety, and potential off-target effects.
[DOI] [PubMed] [Google Scholar] 176.Chen X., Pu H., Fang Y., Wang X., Zhao S., Lin Y., Zhang M., Dai H.E., Gong W., Liu L
PMID 27049945
10.1016/j.resmic.2008.11.002 29 JavdanB.LopezJ
